
Please try another search
Entera Bio Ltd., a clinical stage company, focuses on developing oral peptide or protein replacement therapies for unmet medical needs. The company leverages its N-Tab platform that is designed to simultaneously stabilize the peptide in the gastrointestinal tract and promote its absorption into the bloodstream. It also develops EB613, an oral PTH (1-34), that has completed Phase 2 clinical trial for the treatment of post-menopausal women with low bone mineral density and high-risk osteoporosis; and has completed Phase 1 clinical trial to treat stress fractures. In addition, the company is developing EB612, a tablet peptide replacement therapy for hypoparathyroidism. Further, it develops oral oxyntomodulin (OXM), a dual targeted GLP1/glucagon peptide, in tablet form for the treatment of obesity and metabolic disorders; and GLP-2 peptide tablet as an injection-free alternative for patients suffering from rare malabsorption conditions, such as short bowel syndrome. The company has research collaboration agreement with OPKO Biologics, Inc. Entera Bio Ltd. was incorporated in 2009 and is headquartered in Jerusalem, Israel.
Name | Age | Since | Title |
---|---|---|---|
Gerald M. Lieberman | 75 | 2014 | Independent Chairman of the Board |
Yonatan Malca | 56 | 2011 | Independent Director |
Gerald M. Ostrov | 73 | 2019 | Independent Director |
Miranda J. Toledano | 45 | 2018 | CEO & Director |
Sean Ellis | 50 | 2019 | Independent Director |
Felicia Cosman | - | 2022 | Chairman of Scientific Advisory Board |
John P. Bilezikian | - | - | Member of Scientific Advisory Board |
Steven R. Goldstein | 74 | 2023 | Member of Clinical & Scientific Advisory Board |
Maria Luisa Brandi | - | - | Member of Scientific Advisory Board |
Haya Taitel | 62 | 2023 | Non-Employee Independent Director |
Serge Ferrari | - | 2024 | Member of Scientific Advisory Board |
Bruce Mitlak | - | 2025 | Member of Scientific Advisory Board |
Rogely Boyce | - | 2025 | Member of Scientific Advisory Board |
Bente Langdahl | - | 2024 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review